Robot with AI aims to make colorectal cancer surgery safer

NCT ID NCT07371832

Recruiting now Disease control Sponsor: Asian Institute of Gastroenterology, India Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether an AI-enabled robotic stapler can reduce complications like leaks after colorectal cancer surgery compared to a standard stapler. About 200 adults undergoing planned robotic or laparoscopic surgery for non-metastatic colorectal cancer will be enrolled. The AI stapler helps guide the surgeon on optimal firing angles and clamping to improve precision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-enabled SureForm™ Robotic Stapler
What this could lead to: If successful, this could lead to safer colorectal cancer surgeries with fewer complications like anastomotic leaks.
What could go wrong: This is a single-center, early-stage trial with 200 participants, so results may not apply broadly. The AI stapler may not significantly outperform the conventional method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AIG Hospitals
RECRUITING

Hyderabad, Telangana, 500032, India

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.